Oncology Today with Dr Neil Love Research To Practice

Dr Benjamin Levy from Johns Hopkins comments on changes to the surgical and targeted treatment of lung cancer during COVID-19 and challenges in the management of immune-related adverse events with immune checkpoint inhibitors.


RTP Lung Cancer Summit Presentations


Additional Resources



Banna G et al. How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere. ESMO Open 2020;5(2). Abstract

Kumar S et al. Alternative multidisciplinary management options for locally advanced non-small cell lung cancer during the COVID-19 global pandemic. J Thorac Oncol 2020;[Online ahead of print]. Abstract

Thoracic Surgery Outcomes Research Network, Inc. COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network. Ann Thorac Surg 2020;[Online ahead of print]. Abstract

Dr Kathleen Moore from the Stephenson Cancer Cetner and co-chair of the SGO 2020 Annual Meeting discusses COVID guidelines and the impact of the pandemic on clinical research and the treatment of ovarian cancer.



Akladios C et al. Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN Group for the CNGOF. J Gynecol Obstet Hum Reprod 2020;[Online ahead of print]. Abstract
Dowdy S, Fader AN. Surgical considerations for gynecologic oncologists during the COVID-19 pandemic. SGO 2020. https://www.sgo.org/clinical-practice/management/covid-19-resources-for-health-care-practitioners/surgical-considerations-for-gynecologic-oncologists-during-the-covid-19-pandemic/
Monk B et al. COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies. Gynecol Oncol 2020;[Online ahead of print]. Abstract
Mueller B. Telemedicine arrives in the UK: '10 years of change in one week.' New York Times, April 4, 2020. https://www.nytimes.com/2020/04/04/world/europe/telemedicine-uk-coronavirus.html
Ramirez PT et al. COVID-19 global pandemic: Options for management of gynecologic cancers. Int J Gynecol Cancer 2020;[Online ahead of print]. Abstract
Society of Gynecologic Oncology. Gynecologic oncology considerations during the COVID-19 pandemic. https://www.sgo.org/clinical-practice/management/covid-19-resources-for-health-care-practitioners/gyn-onc-considerations-during-covid-19/
Society of Gynecologic Oncology. SGO 2020 Annual Meeting on Women’s Cancer. https://www.sgo.org/education/annual-meeting-on-womens-cancer/

Dr Julie Gralow, Director of Breast Medical Oncology at the Seattle Cancer Care Alliance, reviews how telemedicine and the screening, diagnosis and treatment of breast cancer have rapidly adapted based on resource limitations and risk factors related to COVID-19.


Additional Resources



Soran A et al. Breast cancer diagnosis, and follow-up during COVID-19 pandemic. Eur J Health 2020;16(2):86-8. Abstract
American College of Surgeons. COVID-19 guidelines for triage of breast cancer patients. https://www.facs.org/covid-19/clinical-guidance/elective-case/breast-cancer
Falandry C et al. Challenges with the management of older patients with cancer during the COVID-19 pandemic. J Geriatri Oncol 2020;[Online ahead of print]. Abstract

Dr Leora Horn of Vanderbilt University Medical Center discusses outcomes for patients with lung cancer and COVID-19 as well as the human implications of social distancing.


Additional Resources



AACR Virtual Annual Meeting I: April 27-28, 2020.
COVID-19 and Cancer. AACR 2020. Session
Garassino, MC. TERAVOLT (Thoracic cancERs international coVid 19 cOLlaboraTion): First results of a global collaboration to address the impact of COVID-19 in patients with thoracic malignancies. AACR 2020. Abstract
Minello A. The pandemic and the female academic. Nature 2020;[Online ahead of print]. Abstract

Dr Harold Burstein discusses how breast cancer is currently being managed at the Dana-Farber Cancer Institute with the constraints of social distancing and other COVID-19 considerations.


COVID-19-Related Resources in Breast Cancer


Dietz JR et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. The COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat 2020;[Online ahead of print]. Abstract


Braunstein LZ et al. Breast radiotherapy under COVID-19 pandemic resource constraints —Approaches to defer or shorten treatment from a Comprehensive Cancer Center in the United States. Adv Radiat Oncol 2020;[Online ahead of print]. Abstract


Coles CE et al. International guidelines on radiation therapy for breast cancer during the COVID-19 pandemic. Clin Oncol (R Coll Radiol) 2020;32(5):279-81. https://www.clinicaloncologyonline.net/article/S0936-6555(20)30122-9/pdf


ESMO. ESMO management and treatment adapted recommendations in the COVID-19 era: Breast Cancer. https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic/breast-cancer-in-the-covid-19-era

In this second episode of our new podcast series, Dr Tom Lynch, who began his position as director of the Fred Hutchinson Cancer Research Center as Seattle became the first epicenter of the COVID-19 pandemic in the United States, comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the EGFR TKI osimertinib as adjuvant therapy for patients with non-small cell lung cancer and EGFR tumor mutations.


Additional resources:



Lynch TJ et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350(21):2129-39. Abstract
AstraZeneca. [Osimertinib] Phase III ADAURA trial will be unblinded early after overwhelming efficacy in the adjuvant treatment of patients with EGFR-mutated lung cancer [press release]. April 10, 2020.
National Comprehensive Cancer Network. Short-term recommendations for non-small cell lung cancer management during the COVID-19 pandemic. COVID-19 NCCN guidelines.